Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor.
about
Pseudohyperaldosteronism: pathogenetic mechanismsAldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathyAldosterone modulates I(f) current through gene expression in cultured neonatal rat ventricular myocytesGenome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities StudiesEndothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation.Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line.Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes.Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin.Regulation of mineralocorticoid receptor expression during neuronal differentiation of murine embryonic stem cells.Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy.Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonatesGain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice.The protective side of the mineralocorticoid receptor.Genetic manipulation of 11beta-hydroxysteroid dehydrogenases in mice.The mineralocorticoid receptor: insights into its molecular and (patho)physiological biologyConditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias.Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons.Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.Mineralocorticoid receptor activation in obesity hypertension.SGK1-sensitive renal tubular glucose reabsorption in diabetes.Rac1 in human diseases: The therapeutic potential of targeting Rac1 signaling regulatory mechanisms.Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction.Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex.Mineralocorticoid receptor overexpression in embryonic stem cell-derived cardiomyocytes increases their beating frequency.Comparison of the effects of intrapericardial and intravenous aldosterone infusions on left ventricular fibrosis in rats.Association of SGK1 gene polymorphisms with type 2 diabetes.Serum- and glucocorticoid-inducible kinase 1 in doxorubicin-induced nephrotic syndrome.Aldosterone, ion channels, and sudden death: another piece of the circle?Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.Paradoxical resistance to high-fat diet-induced obesity and altered macrophage polarization in mineralocorticoid receptor-overexpressing mice.
P2860
Q28191206-1C20E03C-348B-482A-B077-1D3369483199Q28570951-A1E66EE9-518B-46AD-BE81-EAC370E4EC5CQ28580332-F9FE3076-DAA2-4DE2-AA41-968DF87A6399Q33340170-7D050E98-A879-4628-ACB4-A90DBF0F0462Q33856656-E8D6274C-6446-4C7A-9011-0BC52320D72DQ34065505-A9905DCA-F641-497E-BCF0-FD414EF72E19Q34068717-A6A98DA0-7B58-4E4E-8D85-0F4F773F1D88Q34759691-24FD2405-D479-470C-9DED-64AA408BD078Q35023717-6C8C8282-BDFB-4515-854A-3B3D035F8C81Q35130314-747165CA-BA9D-4B31-A7C2-B6AD234E88E7Q35447336-DFCE0513-C039-4C96-A29D-55A3F72D64DEQ35839992-A55E845D-9186-4AAC-8B16-0DCDF9DAC8F4Q35872736-8EB55776-C122-4674-8C3F-32AED4D4E190Q36232568-5DFB8445-1363-4D2B-8B31-8ACD91CC4B40Q36238325-9E3288E4-800E-47CB-AD6D-F4F2940853BCQ36793743-2635AF70-4095-463D-A79F-46D4EB39F24AQ36804573-C18C7197-93C7-4E6F-A7E4-752CECD2202CQ37366263-8BABC3F7-0C87-4CC7-B291-EFE387091959Q37517178-3EAC3987-FE7D-408F-861F-5B9E6227769FQ37680918-4407D858-A02A-45D3-B1F7-75D1DA35EF17Q38839225-822F0B5B-4EE5-4921-98F0-DFA5CF478787Q39579480-1DEC02DD-E7C6-4B67-8A7A-B6B5E4C60358Q39674733-C94AD7C5-5797-4B9E-8437-503AA095BBFDQ39726044-74E3E047-506E-4124-A27F-D692C6EE3CFCQ45231099-7DE96D2A-1D6F-474C-8D72-D75FFD596ABDQ46240581-7D24FAB1-9DAA-403C-A232-4FCC60A6B8CFQ46392319-0C1C507C-5FFF-45A1-BCFF-F7845E758FB0Q46976034-E5CBC310-5F6E-4988-9FA0-F822F98377FCQ51464359-D9197352-76AF-4901-B2ED-28C3E04C5232Q54614555-ADA23701-7F07-4A61-91BC-413C1061D992
P2860
Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Alteration of cardiac and rena ...... an mineralocorticoid receptor.
@en
type
label
Alteration of cardiac and rena ...... an mineralocorticoid receptor.
@en
prefLabel
Alteration of cardiac and rena ...... an mineralocorticoid receptor.
@en
P2093
P2860
P356
P1476
Alteration of cardiac and rena ...... an mineralocorticoid receptor.
@en
P2093
Le Menuet D
Muffat-Joly M
Viengchareun S
Zennaro MC
P2860
P304
38911-38920
P356
10.1074/JBC.M103984200
P407
P577
2001-08-08T00:00:00Z